Hong Kong Journal of Nephrology
Volume 7, Issue 1 , Pages 14-21, April 2005

The Beneficial Effect of Oral Sodium Bicarbonate in Peritoneal Dialysis Patients — How Long Does It Last After Stopping Treatment?

Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China

Article Outline

Background

Acidosis is a major feature of progressive malnutrition in dialysis patients. Our previous study showed that in peritoneal dialysis (PD) patients with mild acidosis, oral sodium bicarbonate improved nutritional status and reduced hospitalization. However, the required duration of bicarbonate treatment remains unknown. Methods: Patients who participated in our previously reported randomized, controlled study of sodium bicarbonate therapy (J Am Soc Nephrol 2003;14:2119-26) were followed for another 12 months after treatment was stopped. We compared the two groups (i.e. sodium bicarbonate therapy vs placebo) with regard to nutritional status, including subjective global assessment (SGA) score and normalized protein nitrogen appearance (NPNA), and hospitalization and mortality.

Results

In the treatment group, the overall SGA score tended to fall to the pretreatment level 12 months after bicarbonate therapy was stopped (5.15 ± 1.04 to 4.68 ± 0.99, p = 0.08). After 12 months, there was no difference in overall SGA score between the treatment and placebo groups (4.68 ± 0.99 vs 4.58 ± 1.10, p = 0.5). NPNA of the treatment group remained marginally higher than that of the placebo group (1.21 ± 0.49 vs 1.06 ± 0.49 g/kg/day, p = 0.21), although the difference was not statistically significant. There was no significant difference in the duration of hospitalization between groups after bicarbonate was stopped (12.3 ± 19.9 vs 16.9 ± 23.7 days/year; Kruskal-Wallis test, p = 0.31). The treatment group had a slightly higher actuarial patient survival (83.3% vs 76.7%; log-rank test, p = 0.22), but the difference was not statistically significant.

Conclusion

The therapeutic benefits of oral sodium bicarbonate disappeared rapidly when treatment was stopped. Our results suggest that oral sodium bicarbonate is beneficial in PD patients with borderline dialysis adequacy and mild metabolic acidosis, and that these patients require long-term bicarbonate treatment.

Key words:  continuous ambulatory peritoneal dialysis , metabolic acidosis , mortality , nutritional status , sodium bicarbonate

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Mitch WE , Goldberg AL . Mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway . N Engl J Med . 1997;335:1897–1905
  2. Mitch WE , Medina R , Greiber S , May RC , England BK , Price SR , et al.   Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes . J Clin Invest . 1994;93:2127–2133
  3. England BK , Greiber S , Mitch WE , Bowers BA , Herring WJ , McKean M , et al.   Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia . Am J Physiol . 1995;268:C1395–C1400
  4. Isozaki U , Mitch WE , England BK , Price SR . Protein degradation and increased mRNAs encoding proteins of the ubiquitinproteasome proteolytic pathway in BC3H1 myocytes require interaction between glucocorticoids and acidification . Proc Natl Acad Sci USA . 1996;93:1967–1971
  5. Bailey JL , Wang X , England BK , Price SR , Ding X , Mitch WE . The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway . J Clin Invest . 1996;97:1447–1453
  6. Reaich D , Channon SM , Scrimgeour CM , Daley SE , Wilkinson R , Goodship THJ . Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation . Am J Physiol . 1993;265:E230–E235
  7. Graham KA , Reaich D , Channon SM , Downie S , Goodship TH . Correction of acidosis in hemodialysis decreases whole-body protein degradation . J Am Soc Nephrol . 1997;8:632–637
  8. Graham KA , Reaich D , Channon SM , Downie S , Gilmour E , Passlick-Deetjen J , et al.   Correction of acidosis in CAPD decreases whole body protein degradation . Kidney Int . 1996;49:1396–1400
  9. Pickering WP , Price SR , Bircher G , Marinovic AC , Mitch WE , Walls J . Nutrition in CAPD: serum bicarbonate and the ubiquitinproteasome system in muscle . Kidney Int . 2002;61:1286–1292
  10. Szeto CC , Wong TY , Chow KM , Leung CB , Li PK . Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients - a randomized placebo-control trial . J Am Soc Nephrol . 2003;14:2119–2126
  11. Tranaeus A , Heimburger O , Lindholm B , Bergstrom J . Six years experience of CAPD at one centre: a survey of major findings . Perit Dial Int . 1988;8:31–41
  12. Robson MD , Faivoseviz A , Malmoud H . Physiological transfer of acid base. . In:  Legrain M editors. Continuous Ambulatory Peritoneal Dialysis. Proceedings of an International Symposium. . Amsterdam: Excerpta Medica; 1980;p. 194
  13. Nolph KD , Moore HL , Twardowski ZJ , Khanna R , Prowant B , Meyer M , et al.   Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis . ASAIO J . 1992;38:M139–M142
  14. Van Olden RW , Krediet RT , Struijk DG , Arisz L . Measurement of residual renal function in patients treated with continuous peritoneal dialysis . J Am Soc Nephrol . 1996;7:745–748
  15. Mak TW , Cheung CK , Cheung CM , Leung CB , Lam CW , Lai KN . Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations . Nephrol Dial Transplant . 1997;12:184–186
  16. II. NKF-K/DOQI Clinical practice guidelines for peritoneal dialysis adequacy: update 2000 . Am J Kidney Dis . 2001;37(Suppl 1):S65–136
  17. Enia G , Sicus C , Alati G , Zoccali C . Subjective global assessment of nutrition in dialysis patients . Nephrol Dial Transplant . 1993;8:1094–1098
  18. Bergstrom J , Heimburger O , Lindholm B . Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? . Perit Dial Int . 1998;18:467–473
  19. Watson PE , Watson ID , Batt RD . Total body water volumes for adult males and females estimated from simple anthropometric measurements . Am J Clin Nutr . 1980;33:27–39
  20. Forbes GB , Bruining GJ . Urinary creatinine excretion and lean body mass . Am J Clin Nutr . 1976;29:1359–1366
  21. Reaich D , Channon SM , Scrimgeour CM , Goodship THJ . Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans . Am J Physiol . 1992;263:E735–E739
  22. May RC , Kelly RA , Mitch WE . Mechanisms for defects in muscle protein catabolism in rats with chronic uraemia . J Clin Invest . 1987;79:1099–1103
  23. Wing SS , Goldberg AL . Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting . Am J Physiol . 1993;264:E668–E676
  24. Kooman JP , Deutz NE , Zijlmans P , van den Wall Bake A , Gerlag PG , van Hooff JP , et al.   The influence of bicarbonate supplementation on plasma levels of branched-chain amino acids in hemodialysis patients with metabolic acidosis . Nephrol Dial Transplant . 1997;12:2397–2401
  25. Lin SH , Lin YF , Chin HM , Wu CC . Must metabolic acidosis be associated with malnutrition in hemodialysis patients? . Nephrol Dial Transplant . 2002;17:2006–2010
  26. Seyffart G , Ensminger A , Scholz R . Increase of body mass during long-term bicarbonate hemodialysis . Kidney Int . 1987;22:S174–S177
  27. Roberts RG , Gilmour ER , Goodship TH . The correction of acidosis does not increase dietary protein intake in chronic renal failure patients . Am J Kidney Dis . 1996;28:350–353
  28. Movilli E , Zani R , Carli O , Sangalli L , Pola A , Camerini C , et al.   Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study . Nephrol Dial Transplant . 1998;13:1719–1722
  29. Verove C , Maisonneuve N , El Azouzi A , Boldron A , Azar R . Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure . J Ren Nutr . 2002;12:224–228
  30. Mehrotra R , Kopple JD , Wolfson M . Metabolic acidosis in maintenance dialysis patients: clinical considerations . Kidney Int . 2003;64(Suppl 88):S13–S25
  31. Williams AJ , Dittmer ID , McArley A , Clarke J . High bicarbonate dialysate in haemodialysis patients: effects on acidosis and nutritional status . Nephrol Dial Transplant . 1997;12:2633–2637
  32. Brady JP , Hasbargen JA . Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients . Am J Kidney Dis . 1998;31:35–40
  33. Stein A , Moorhouse J , Iles-Smith H , Baker F , Johnstone J , James G , et al.   Role of an improvement in acid-base status and nutrition in CAPD patients . Kidney Int . 1997;52:1089–1095
  34. Harty J , Faragher B , Venning M , Gokal R . Urea kinetic modeling exaggerates the relationship between nutrition and dialysis in CAPD patients. (The hazards of cross-sectional analysis.) . Perit Dial Int . 1995;15:105–109

PII: S1561-5413(09)60175-7

doi:10.1016/S1561-5413(09)60175-7

Hong Kong Journal of Nephrology
Volume 7, Issue 1 , Pages 14-21, April 2005